Status:
COMPLETED
Subconjunctival Versus Direct Mitomycin C in Trabeculectomy
Lead Sponsor:
University of California, San Diego
Conditions:
Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Trabeculectomy is routinely used as a surgical treatment for open angle glaucoma. Success of trabeculectomy is greatly augmented by the use of antimetabolites to inhibit wound healing, specifically Mi...
Detailed Description
Trabeculectomy is widely used as a surgical treatment of uncontrolled open glaucoma. Success of trabeculectomy at halting or slowing glaucoma progression primarily relies on the extent of conjunctival...
Eligibility Criteria
Inclusion
- medically uncontrolled glaucoma
- healthy and freely mobile conjunctiva in superior bulbar region
Exclusion
- previous incisional glaucoma surgery
- no light perception vision
- pregnant or nursing women
- iris neovascularization or proliferative retinopathy
- iridocorneal endothelial syndrome
- chronic or recurrent uveitis
- steroid-induced glaucoma
- pathologic myopia or refractive error less than -6.00 diopters
- unwillingness or inability to give consent
- inability to return for scheduled protocol visits
Key Trial Info
Start Date :
May 23 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 14 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04352660
Start Date
May 23 2016
End Date
April 14 2019
Last Update
July 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.